2m 2m 2m 2m 2m 2m 2m
VOR BIOPHARMA (VOR)
NASDAQ
$18.78+$0.08 (+0.45%)
Price as of Oct 02, 2026 7:30 PM EDT- $1.1BMarket Cap
- -50.11%1-Year Change
- BiotechnologyIndustry
VOR BIOPHARMA (VOR)
$18.78+$0.08 (+0.45%)
VOR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $18.69 | ||
Change | +$0.63 (+3.49%) | ||
Open | $18.09 | ||
High | $18.99 | ||
Low | $18.09 | ||
Previous Close | $18.06 | ||
Volume | 773,270 | ||
30-Day Average Volume | 1,287,196 | ||
1-Week Change | 0.92% | ||
1-Month Change | -24.52% | ||
1-Year Change | -50.11% | ||
3-Year Change | -52.20% | ||
5-Year Change | -93.95% | ||
Fundamentals | |||
Shares Outstanding | 59.2M | ||
Total Assets | $481.1M | ||
Market Cap | $1.1B | ||
Enterprise Value | $997.9M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$62.8M | ||
Free Cash Flow | -$25.5M | ||
EBIT | -$62.8M | ||
EBITDA | -$62.8M | ||
Net Working Capital | $450.3M | ||
EPS | -$1.16 | ||
Enterprise Value/EBITDA | -16 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -6 | ||
P/E | -16 | ||
PEG | -0 | ||
Price/Free Cash Flow | -43 | ||
Price/Operating Cash Flow | -44 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 09/19/2025 | ||
Earnings & Revenue